Identification of peptide sequences specific for serum antibodies from human papillomavirus-infected patients using phage display libraries

Clinical Immunology

Volumn 101, Issue 3, 2001, Pages 296-302

  Santamaria, H ^a   Manoutcharian, K ^a   Rocha, L ^a   Gonzalez, E ^a   Acero, G ^a   Govezensky, T ^a   Uribe, L I ^b   Olguin, A ^b   Paniagua, J ^b   Gevorkian, G ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b Laboratorios Silanes SA de CV   (Mexico)

Author keywords

Cervical cancer; Human papillomavirus; Phage display peptide library

Indexed keywords

EPITOPE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; WART VIRUS ANTIBODY;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MOLECULAR CLONING; PHAGE DISPLAY; PRECANCER; PRIORITY JOURNAL; SCREENING TEST; SEQUENCE ANALYSIS; UTERINE CERVIX CARCINOMA IN SITU; VIRUS INFECTION;

EID: 0035207045     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2001.5126     Document Type: Article

References (23)

1. New technologies in cervical cancer precursor detection
2. Do HPV-negativ cervical carcinomas exist?
3. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
4. Antibodies against the human papillomavirus type 16 early proteins in human sera: Correlation of anti-E 7 reactivity and cervical cancer
5. Occurrence of IgA and IgG antibodies to select peptides representing human papillomavirus type 16 among cervical cancer patients and controls
6. Occurrence of antibodies to L1, L2, E4 and E7 gene products of human papillomavirus types 6b, 16 and 18 among cervical cancer patients and controls
7. Antibodies to HPV 16 E6 and E7 proteins as markers for HPV 16-associated invasive cervical cancer
8. Differences in serological IgA responses to recombinant baculovirus-derived human papillomavirus E 2 protein in the natural history of cervical neoplasia
9. Antibodiesagainst early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer
10. Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus-like particles in a case-control study of cervical squamous intraepithelial lesions
11. Detection of cervical antibodies to human papillomavirus type 16 (HPV-16) capsid antigens in relation to detection of HPV- 16 DNA and cervical lesions
12. Searching for peptide ligands with epitope library
13. Epitope mapping of anti-HIV and anti-HCV monoclonal antibodies and characterization of epitope mimics using a filamentous phage peptide library
14. Screening a monoclonal antibody with a fusion-phage display library shows a discontinuity in a linear epitope within preS 1 of hepatitis B virus
15. Identification of new B cell epitopes in the sera of rheumatoid arthritis patients using a random nanopeptide phage library
16. Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries
17. Characterization of autoantigenic epitopes on platelet glycoprotein IIb/IIIa using random peptide libraries
18. Identification of autoimmune thrombocytopnic purpura-related epitopes using phage-display peptide library
19. Characterization of cerebrospinal fluid antibody specificities in neurocysticercosis using phage display peptide library
20. Small scale preparation of single-stranded bacteriophage M13 DNA
21. Cervical secretory immunoglobulin A to human papillomavirus type 16 (HPV16) from HPV16-infected women inhibit HPV16 virus-like particles-induced hemagglutination of mouse red blood cells
22. A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera
23. Peptides that mimic Candida albicans-derived beta-1,2-linked mannosides